Articles Tagged With:
-
Full August issue in PDF
-
Vancomycin and MRSA: How Susceptible is "Susceptible"?
A laboratory report indicating susceptibility of MRSA to vancomycin does not guarantee successful therapy with this antibiotic since a significant risk for failure may be present despite MICs within the range considered susceptible. -
Which Nocardia Species Is It, Anyway?
Molecular techniques provide a more rapid and accurate method of Nocardia species identification than do classical microbiologic methods. A surprise: of 94 isolates, the most commonly identified species was Nocardia cyriacigeorgica and none were Nocardia asteroides. -
Much More About CRP!
CPR values as a continuous variable have independent predictive value for subsequent coronary events in apparently healthy women. -
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Data showed a strong trend toward benefit with ICD therapy in patients with nonischemic cardiomyopathy. -
Pre-Discharge Beta Blockers for Heart Failure
The pre-discharge initiation of beta blocker therapy for decompensated heart failure patients increased the number of patients on beta blockers at 60 days without an increase in length of stay or adverse effects. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Britain to Allow Over-the-Counter Sales of Zocor
The British government will soon allow over-the-counter sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin. -
Full July 2004 Issue in PDF
-
Mediation offers strategy for ethical conflicts
Mediation long has been known as an alternative way of resolving civil legal disputes. But as the following case study illustrates, it is emerging as a new way to help resolve conflicts in medical settings.